Market Access News | pharmaphorum

News

Novartis gets FDA nod for second of three IgAN drugs

Novartis has claimed accelerated approval in the US for Vanrafia, one of a trio of drugs it hopes will revolutionise the treatment of IgA nephropathy.

News

Pharma in a spin as it tries to gauge Trump tariffs impact

Pharmaceuticals are exempt from the tariffs revealed by President Donald Trump, for now, but the industry is bracing for what may come next.

News

First drug backed for NHS use in untreated Hodgkin lymphoma

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma.

News

President Trump signing an Order at his desk in the Oval Office

Pharma tariffs "will hurt US consumers most of all"

If pharmaceuticals are included in President Trump's 'Liberation Day' tariffs, it is US consumers who will suffer the most, says a new report.

News

Death penalty sought for suspect in UnitedHealth CEO killing

Prosecutors in the US are seeking the death penalty for Luigi Mangione in connection with the assassination of UnitedHealth CEO Brian Thompson.

News

RIF job losses are underway at HHS agencies; reports

Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports.

Novartis gets FDA nod for second of three IgAN drugs

Pharma in a spin as it tries to gauge Trump tariffs impact

First drug backed for NHS use in untreated Hodgkin lymphoma

Pharma tariffs "will hurt US consumers most of all"

Death penalty sought for suspect in UnitedHealth CEO killing

RIF job losses are underway at HHS agencies; reports

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks